Your browser doesn't support javascript.
COVID-19 vaccination and HIV-1 acquisition.
Logunov, Denis Y; Livermore, David M; Ornelles, David A; Bayer, Wibke; Marques, Ernesto; Czerkinsky, Cecil; Dolzhikova, Inna V; Ertl, Hildegund Cj.
  • Logunov DY; NF Gamaleya National Research Centre for Epidemiology and Microbiology, Moscow, Russia.
  • Livermore DM; Norwich Medical School, University of East Anglia, Norwich, UK.
  • Ornelles DA; Department of Microbiology and Immunology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  • Bayer W; Institute for Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Marques E; Fundação Oswaldo Cruz - FIOCRUZ, Instituto Aggeu Magalhães-IAM, Department of Virology and Experimental Therapeutics, Recife, Brazil; University of Pittsburgh, School of Public Health, Department of Infectious Diseases, Pittsburgh, PA, USA.
  • Czerkinsky C; CNRS, INSERM, Institut de Pharmacologie Moleculaire et Cellulaire, Université Nice Sophia Antipolis, Nice, France.
  • Dolzhikova IV; NF Gamaleya National Research Centre for Epidemiology and Microbiology, Moscow, Russia.
  • Ertl HC; Wistar Institute, Philadelphia, PA 19104, USA. Electronic address: ertl@wistar.org.
Lancet ; 399(10333): e34-e35, 2022 04 09.
Article in English | MEDLINE | ID: covidwho-1778512

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / HIV-1 / HIV Seropositivity / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2022 Document Type: Article Affiliation country: S0140-6736(22)00332-4

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / HIV-1 / HIV Seropositivity / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2022 Document Type: Article Affiliation country: S0140-6736(22)00332-4